Karen McLean

Roswell Park Comprehensive Cancer Center

ORCID: 0000-0001-7833-1967

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer”.

Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer

JCI Insight(2020)10.1172/jci.insight.133247

N/A

3.2DataRank · unranked

193 citations

Daniel Chan, Jessica Shank, Kent A. Griffith, Huihui Fan, Robert Szulawski +17 more

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

Nature(2020)10.1038/s41586-020-2682-1

N/A

0.969DataRank · unranked

637 citations

Wei Li, Daniel M. Kremer, Peter Sajjakulnukit, Shasha Li, Joel Crespo +24 more

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.10.088

N/A

0.516DataRank · unranked

14 citations

Rachel Palmieri Weber, Penelope M. Webb, Susan J. Jordan, Aruna Muthukumar, Jenny Chang‐Claude +25 more

Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.06.481

N/A

0.510DataRank · unranked

29 citations

Siri Peterson, Alice W. Lee, Bhramar Mukherjee, Kelly M. Bakulski, Aliya Alimujiang +46 more

Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1355

N/A

0.464DataRank · unranked

21 citations

Alice W. Lee, Anna H. Wu, Andrew Berchuck, Kathleen R. Cho, Daniel W. Cramer +16 more

High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0977

N/A

0.312DataRank · unranked

7 citations

Minh Tung Phung, Bhramar Mukherjee, Kelly M. Bakulski, Hoda Anton-Culver, Elisa V. Bandera +43 more

Pelvic Recovery After Endometrial Cancer Treatment: Patient-Reported Outcomes and MRI Findings

Academic Radiology(2023)10.1016/j.acra.2023.03.031

N/A

0.208DataRank · unranked

3 citations

Marisa F. Martin, Christina Chapman, Karen McLean, B.N. Michaels, Shitanshu Uppal +4 more

A framework for assessing interactions for risk stratification models: the example of ovarian cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad137

N/A

0.208DataRank · unranked

3 citations

Alice W. Lee, Karen McLean, Hoda Anton‐Culver, Elisa V. Bandera, Michael E. Carney +26 more

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.018

N/A

0.165DataRank · unranked

2 citations

Penelope M. Webb, Anna deFazio, Sián Fereday, Alice W. Lee, David D.L. Bowtell +25 more

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle

Nature Communications(2025)10.1038/s41467-025-56674-4

N/A

0DataRank · unranked

35 citations

Jianxin Wang, Michelle Roti, Yin Wan, Adam P. Dommer, Hanna R. Rosenheck +11 more

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis

JCI Insight(2020)10.1172/jci.insight.141115

N/A

0DataRank · unranked

124 citations

Shasha Li, Xiong Li, Weichao Wang, Yingjie Bian, Shuang Wei +11 more

Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches

Translational Oncology(2024)10.1016/j.tranon.2024.102119

N/A

0DataRank · unranked

4 citations

Lijun Tan, Brianna P. Cunneen, Caroline Foster, Yu L. Lei, Karen McLean +1 more

Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients

Gynecologic Oncology Reports(2024)10.1016/j.gore.2024.101498

N/A

0DataRank · unranked

1 citations

Kara J. Milliron, Jean Siedel, Shitanshu Uppal, Sofía D. Merajver, Karen McLean +1 more